Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

BACKGROUND: An increasing proportion of patients are exposed to anthracyclines and/or taxanes in the adjuvant or neoadjuvant setting. Re-exposure in the metastatic stage is limited by drug resistance, thus evaluation of non-cross-resistant regimens is mandatory. METHODS: Anthracycline-pretreated pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Stemmler, H J, diGioia, D, Freier, W, Tessen, H W, Gitsch, G, Jonat, W, Brugger, W, Kettner, E, Abenhardt, W, Tesch, H, Hurtz, H J, Rösel, S, Brudler, O, Heinemann, V
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068513/
https://www.ncbi.nlm.nih.gov/pubmed/21407218
http://dx.doi.org/10.1038/bjc.2011.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068513/
https://www.ncbi.nlm.nih.gov/pubmed/21407218
http://dx.doi.org/10.1038/bjc.2011.86

Ejemplares similares